Literature DB >> 18189302

Potential effects of a low-molecular-weight fucoidan extracted from brown algae on bone biomaterial osteoconductive properties.

S Igondjo Tchen Changotade1, G Korb, J Bassil, B Barroukh, C Willig, S Colliec-Jouault, P Durand, G Godeau, K Senni.   

Abstract

In this work, we first tested the influence of low-molecular-weight (LMW) fucoidan extracted from pheophicae cell wall on bidimensional cultured normal human osteoblasts' behaviors. Second, by impregnation procedure with LMW fucoidan of bone biomaterial (Lubboc), we explored in this bone extracellular matrix context its capabilities to support human osteoblastic behavior in 3D culture. In bidimensionnal cultures, we evidenced that LMW fucoidan promotes human osteoblast proliferation and collagen type I expression and favors precocious alkaline phosphatase activity. Furthermore, with LMW fucoidan, von Kossa's staining was positive at 30 days and positive only at 45 days in the absence of LMW fucoidan. In our three-dimensional culture models with the biomaterial pretreated with LMW fucoidan, osteoblasts promptly overgrew the pretreated biomaterial. We also evidenced that osteoblasts increased proliferation with pretreated biomaterial when compared with untreated biomaterial. Osteoblasts secreted osteocalcin and expressed BMP2 receptor on control material as well as with LMW fucoidan impregnated biomaterial. In conclusion, in our experimental conditions, LMW fucoidan stimulated expression of osteoblastic markers differentiation such as alkaline phosphatase activity, collagen type I expression, and mineral deposition; furthermore, cell proliferation was favored. These findings suggest that fucoidan could be clinically useful for bone regeneration and bone substitute design. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18189302     DOI: 10.1002/jbm.a.31819

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  17 in total

1.  The in vitro and in vivo effects of the low molecular weight fucoidan on the bone osteogenic differentiation properties.

Authors:  Pai-An Hwang; Yu-Lan Hung; Nam Nhut Phan; Bui-Thi-Ngoc Hieu; Po-Ming Chang; Kuan-Lun Li; Yen-Chang Lin
Journal:  Cytotechnology       Date:  2015-08-14       Impact factor: 2.058

2.  Low Molecular Weight Mannogalactofucans Derived from Undaria pinnatifida Induce Apoptotic Death of Human Prostate Cancer Cells In Vitro and In Vivo.

Authors:  Jisun Lee; Seul Lee; Andriy Synytsya; Peter Capek; Chang Won Lee; Ji Won Choi; Sarang Cho; Woo Jung Kim; Yong Il Park
Journal:  Mar Biotechnol (NY)       Date:  2018-08-29       Impact factor: 3.619

3.  Evaluation of MxOy/fucoidan hybrid system and their application in lipase immobilization process.

Authors:  Agnieszka Kołodziejczak-Radzimska; Michał Bielejewski; Andrzej Biadasz; Teofil Jesionowski
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

Review 4.  Recent trends in the application of widely used natural and synthetic polymer nanocomposites in bone tissue regeneration.

Authors:  Angshuman Bharadwaz; Ambalangodage C Jayasuriya
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-01-29       Impact factor: 7.328

Review 5.  Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering.

Authors:  Karim Senni; Jessica Pereira; Farida Gueniche; Christine Delbarre-Ladrat; Corinne Sinquin; Jacqueline Ratiskol; Gaston Godeau; Anne-Marie Fischer; Dominique Helley; Sylvia Colliec-Jouault
Journal:  Mar Drugs       Date:  2011-09-23       Impact factor: 6.085

6.  Chitosan-alginate biocomposite containing fucoidan for bone tissue engineering.

Authors:  Jayachandran Venkatesan; Ira Bhatnagar; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2014-01-16       Impact factor: 5.118

7.  Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.

Authors:  Beom Su Kim; Hyo-Jin Kang; Ji-Yun Park; Jun Lee
Journal:  Exp Mol Med       Date:  2015-01-09       Impact factor: 8.718

8.  Fucoidan, a sulfated polysaccharide, inhibits osteoclast differentiation and function by modulating RANKL signaling.

Authors:  Young Woo Kim; Seung-Hoon Baek; Sang-Han Lee; Tae-Ho Kim; Shin-Yoon Kim
Journal:  Int J Mol Sci       Date:  2014-10-20       Impact factor: 5.923

Review 9.  Fucoidans in Nanomedicine.

Authors:  Lucas Chollet; Pierre Saboural; Cédric Chauvierre; Jean-Noël Villemin; Didier Letourneur; Frédéric Chaubet
Journal:  Mar Drugs       Date:  2016-07-29       Impact factor: 5.118

Review 10.  Bioactive Compounds from Marine Organisms: Potential for Bone Growth and Healing.

Authors:  Matthew A Carson; Susan A Clarke
Journal:  Mar Drugs       Date:  2018-09-18       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.